New diet approaches in irritable bowel syndrome

Yıl 2019, Cilt: 1 Sayı: 1, 1 - 6, 13.03.2019

Elif Ede , Havvanur Yoldaş İlktaç

Öz

Irritable
bowel syndrome (IBS) is a functional bowel disease characterized by a change in
intestinal motility, the cause of which is unknown. The incidence of IBS in
societies varies between 10-25%. IBS, which is not a life-threatening disease,
has many symptoms, such as abdominal pain or discomfort in the abdomen,
diarrhea, constipation and bloating, which significantly affect the quality of
life. Since IBS is idiopathic, treatment with IBS is designed to alleviate
symptoms. All these symptoms, which greatly affect the quality of life, can be
exacerbated or diminished depending on the individual's eating habits. In this
review, it is aimed to provide an overview of nutritional therapy and current
nutritional therapy approaches in irritable bowel syndrome. For this purpose,
the efficacy of FODMAPs diet, vitamin D, prebiotic and probiotic supplements in
IBS nutritional therapy was investigated.

Anahtar Kelimeler

Irritable Bowel Syndrome, Nutrition, FODMAPs, Vitamin D, Prebiotics and Probiotics

İrritable Bağırsak Sendromunda Güncel Diyet Yaklaşımları

Öz

İrritable
bağırsak sendromu (İBS) nedeni bilinmeyen, bağırsak hareketlerinde değişiklik
ile karakterize fonksiyonel bir bağırsak hastalığıdır. İBS’nin toplumlarda
görülme sıklığı %10-25 arasında değişiklik göstermektedir. Hayatı tehdit edici
bir hastalık olmayan İBS’nin hayat kalitesini önemli ölçüde etkileyen karın
ağrısı veya karında rahatsızlık hissi, ishal, kabızlık ve şişkinlik gibi birçok
semptomu bulunmaktadır. İBS’nin idiyopatik olması sebebiyle İBS tedavisi
semptomları hafifletmeye yönelik  olarak
yapılmaktadır. Hayat kalitesini büyük ölçüde etkileyen tüm bu semptomlar
bireyin beslenme alışkanlıklarına göre şiddetlenebilmekte veya
hafifleyebilmektedir. Bu derlemede, irritable bağırsak sendromunda beslenme
tedavisinin öneminin ve güncel beslenme tedavisi yaklaşımlarının ortaya konması
amaçlanmaktadır. Bu amaçla İBS beslenme tedavisinde FODMAPs diyeti, D vitamini,
prebiyotik ve probiyotik takviyelerinin etkinliği incelenmiştir.

Anahtar Kelimeler

Irritable Bağırsek Sendromu, Beslenme, FODMAPs, D vitamini, Prebiyotikler ve Probiyotikler

Kaynakça

• Abbasnezhad, A., Amani, R., Hajiani, E., Alavinejad, P., Cheraghian, B., Ghadiri, A. (2016). Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrom patients: a randomized double-blind clinical trial. Journal Of Neurogastroenterology And Motılıty 28 (10):1533–1544, doi: 10.1111/nmo.12851.
• Barrett, J.S. (2013). Extending our knowledge of fermentable, short-chain carbohydrates for managing gastrointestinal symptoms. Nutrıtıon In Clınıcal Practıce. 28(3):300-6, doi: 10.1177/0884533613485790.
• Baştürk, A., Artan, R., Yılmaz, A. (2016). Efficacy of synbiotic, probiotic, and prebiotic treatments for irritable bowel syndrome in children: A randomized controlled trial. The Turkısh Journal Of Gastroenterology, 27: 439-43, doi: 10.5152/tjg.2016.16301.
• Can, G., Yılmaz, B. (2015). İrritabl Barsak Sendromunun Tanı ve Tedavisinde Yaklaşımlar, Güncel Gastroenteroloji. 19(3):171-181, doi: 10.5152/tjg.2016.16301.
• Canavan, C., West, J., Card, T. (2014). The epidemiology of irritable bowel syndrome, Clınıcal Epıdemıology. 2014(6):71–80, doi: 10.2147/CLEP.S40245.
• Coussens, A.K., Martineau, A.R., Wilkinson, R.J. (2014). Anti-inflammatory and antimicrobial actions of vitamin D in combating Tb/Hıv. Scıentıfıca. Article ID 903680, 13 pages, http://dx.doi.org/10.1155/2014/903680.
• Çelebi, S., Açıkk, Y., Deveci, S.E. (2004). Epidemiological features of irritable bowel syndrome in a Turkish urban society, Journal Of Gastroenterology And Hepatology, 19(7):38-43, doi: 10.1111/j.1440-1746.2004.03367.x.
• Drossman, D.A., Chang, L., Bellamy, N. (2001). Severity in irritable bowel syndrome: a Rome Foundation Working Team report, THE Amerıcan Journal Of Gastroenterology, 106(10):1749-1760, doi: 10.1038/ajg.2011.201.
• Eswaran, S., Tack, J., Chey, W.D. (2011). Food: the forgotten factor in the irritable bowel syndrome. Gastroenterology Clınıcs Of North Amerıca. 40(1):141-162, doi:10.1016/j.gtc.2010.12.012.
• Halmos, E.P., Power, V.A., Shepherd, S.J. (2014). A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology.146(1): 67, doi: 10.1053/j.gastro.2013.09.046.
• Kanazawa, M., Hongo, M., Fukudo, S. (2011) Visceral hypersensitivity in irritable bowel syndrome. Journal Of Gastroenterology And Hepatology. 26(3):119, doi: 10.1111/j.1440-1746.2011.06640.x.
• Karaman, N., Türkay, C., Yönem, O. (2003). Irritable bowel syndrome prevalence in city center of Sivas. THE Turkısh Journal Of Gastroenterology, 14(1):28-31, PMID: 14614640.
• Khan, S., Chang, L. (2010). Diagnosis and management of Ibs. Nature Revıews Gastroenterology & Hepatology. 7(10): 565-81, doi: 10.1038/nrgastro.2010.137.
• Koff, A., Mullin, G.E. (2012). Nutrıtıon In Irrıtable Bowel Syndrome. Boca Raton, Fla, CRC Press.
• Kong, J., Zhang, Z., Musch, M.W., Ning, G., Sun, J., Hart, J., Bissonnette, M., Li, Y.C. (2008). Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Amerıcan Journal Of Physıology-Gastroıntestınal And Lıver Physıology. 294(1):208–16, doi: 10.1152/ajpgi.00398.2007.
• Lovell, R.M., Ford, A.C. (2012). Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clınıcal Gastroenterology And Hepatology, 10(7):712–721, doi: 10.1016/j.cgh.2012.02.029.
• Mahan, L.K., Raymond, J.L. (2016). Krause’s Food And Nutrıtıon Care Process. Seattle, WA. Elsevier. Mckenzie, Y.A. (2016). British Dietetic practice guidelines for the dietary management of irritable bowel syndrome in adults. Journal Of Human Nutrition And Dıetetıcs. 29(5):549-75, doi: 10.1111/jhn.12385.
• Mezzasalma, V., Manfrini, E., Ferri, E. (2016). Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation. Biomed Research Internatıonal, Article ID 4740907, 10 pages, doi: 10.1155/2016/4740907.
• Mullın, G.E., Shepherd, S.J., Chander Roland, B., Ireton-Jones, C., Matarese, L.E.(2014). Irritable Bowel Syndrome: Contemporary Nutrition Management Strategies, Journal Of Parenteral And Enteral Nutrıtıon 38(7):781– 799, doi: 10.1177/0148607114545329.
• Occhipinti, K., Smith, J.W. (2012). Irritable Bowel Syndrome: A Review and Update. Clınıcs In Colon And Rectal Surgery. 25(1):46-52, doi: 10.1055/s-0032-1301759. Özdemir, M., Perktaş, G. (2016). İrritable Bağırsak Sendromunda Diyet. Güncel Gastroenteroloji. 20(3): 274-279, doi: 10.1155/2016/5105108.
• Silk, D.B., Davis, A., Vulevic, J., Tzortzis, G., Gibson, G.R. (2009). Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota And Symptoms İn İrritable Bowel Syndrome. Alımentary Pharmacology & Therapeutıcs. 29 (5): 508–518, doi: 10.1111/j.1365-2036.2008.03911.x.
• Surdea-Blaga, T., Baban, A., Dumitrascu, D.L. (2012). Psychosocial determinants of irritable bowel syndrome. World Journal Of Gastroenterology. 18(7):616-626, doi: 10.3748/wjg.v18.i7.616.
• Tüfekçi Alphan, M.E. (2013). Hastalıklarda Beslenme Tedavisi. Ankara. Hatiboğlu Yayınevi.
• Ünal, H.Ü. (2012). İrritabl barsak sendromu. Güncel Gastroenteroloji. 16(3):213-217, http://guncel.tgv.org.tr/journal/42/pdf/100083.pdf.
• Whelan, K. (2013). Mechanism and effectiveness of prebiotics in modifying the gastrointestinal microbiota for the management to digestive disorders. Proceedings Of The Nutrıtıon Socıety. 72(3):288-98, doi: 10.1017/S0029665113001262.
• Zhan, Y.L., Zhan, Y.A., Dai, S.X. (2018), Is a low FODMAP diet beneficial for patients with inflammatory bowel disease? A meta-analysis and systematic review, Clinical Nutrition, 37 (1), 123-129, doi: 10.1016/j.clnu.2017.05.019.